Study on the Review of Policies on the Misuse and Abuse of Substances
WITNESSES:
Canadian Pharmaceutical Association:
Leroy Fevang, Director General;
Noëlle-Dominique Willems, Director of Government and Public Affairs.
Click here to view Committee Evidence